Swipe om te navigeren naar een ander artikel
Defibrillator lead advisories stir a lot of emotions, both with patients and physicians, and this may influence lead management. We reviewed the literature for a more evidence-based approach to this issue.
From the complications of two of the current advisory leads, the Medtronic Sprint Fidelis and St. Jude Riata leads, and the consequences of possible interventions, we can conclude that a restrained approach to premature replacement is appropriate. It may be opportune to replace the leads during a scheduled generator replacement in case of a higher electrical failure rate, in order to prevent future premature interventions.
We found no support to extract non-functional advisory leads. In contrast, extraction is often more demanding than anticipated, and the risk substantially exceeds that of simply abandoning the leads.
Theuns DAMJ, Elvan A, Voogt W de, Cock CC de, Erven L van, Meine M. Prevalence and presentation of externalized conductors and electrical abnormalities in Riata defibrillator leads after fluoroscopic screening: report from The Netherlands Heart Rhythm Association Device Advisory Committee. Circ Arrhythm Electrophysiol. 2012;5:1059–63. CrossRefPubMed
http://www.medtronic.com/product-advisories/physician/sprint-fidelis/6949-LEAD–PERFORMANCE. Accessed on 20 February 2015.
Wilkoff BL, Williamson BD, Stern RS, et al. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study. J Am Coll Cardiol. 2008;52:541–50. CrossRefPubMed
Patel D, Adelstein E, Nemec J, et al. Extraction of defibrillator leads recalled for cable externalization and failure. J Interv Card Electrophysiol. 2012;34:105–13. CrossRef
- Managing patients with advisory defibrillator leads: what can we learn from published data?
F. A. Bracke
B. M. van Gelder
- Bohn Stafleu van Loghum